Chinook Therapeutics, Inc. Stock
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
Latest transcript on Chinook Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Noopur Liffick
IRC | Investor Relations Contact | - | 20-09-30 |
Valerie Fauvelle
LAW | General Counsel | - | - |
Sukhi Thethy
AUD | Comptroller/Controller/Auditor | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.03% | 237 M€ | +0.01% | - |
1st Jan change | Capi. | |
---|---|---|
-3.39% | 102B | |
+2.61% | 96.09B | |
-1.02% | 22.05B | |
-18.14% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.89% | 14.01B | |
+1.12% | 13.38B | |
+22.25% | 11.01B |